PARP inhibitors in prostate cancer: What nurses need to know

Episode 2 February 07, 2022 00:24:43
PARP inhibitors in prostate cancer: What nurses need to know
COR2ED Medical Education
PARP inhibitors in prostate cancer: What nurses need to know

Feb 07 2022 | 00:24:43

/

Show Notes

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria in Malaga in Spain, discuss ‘The potential of PARP inhibitors in prostate cancer: What nurses need to know’. 

In this podcast, the experts discuss PARP inhibitors (PARPi’s), how they work and key data from the registration trials for rucaparib and olaparib, TRITON2 and PROfound.  They also discuss how to select PARPi’s for their prostate cancer patients and where they fit in the overall treatment sequence. Pablo provides some insight into communicating with patients, and the types of questions and concerns they often have in relation to genetic testing and treatment with PARPi’s.  In addition, they also discuss the PARPi’s currently in late-stage development such as niraparib and talazoparib as well as the potential future use of PARPi’s in combination with immunotherapies or androgen receptor pathway inhibitors.

Other Episodes

Episode 2

July 04, 2022 00:19:34
Episode Cover

PBC highlights from ILC 2022: ep.2

COR2ED Medical Education: In this podcast episode, Prof. Kris Kowdley, Director, Liver Institute Northwest, Washington State University, USA and Prof. Jörn Schattenberg, Director, Metabolic...

Listen

Episode 1

September 23, 2021 00:18:01
Episode Cover

Diagnosis and treatment of TRK fusion-positive GI cancers

In this podcast, NTRK CONNECT members Prof Frédérique Penault-Llorca (University of Clermont-Ferrand, France) and Prof Andrea Sartore-Bianchi (Niguarda Cancer Centre, Milan, Italy) provide both...

Listen

Episode 23

September 25, 2023 00:27:20
Episode Cover

Cancer and Thrombosis

COR2ED Medical Education: In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss...

Listen